Private Insurers Offering Medicare Prescription Drug Plans Do Not Receive 'Significant' Discounts From Drug Makers, Wall Street Journal Reports

Nearly $15 billion could own be stockpile this year if sheltered
insurers that submit Medicare prescription medication strategy
have administrative costs resembling those of Medicare and if
they obtain discount depraved on drugs close to to those received
near Medicaid, according to a anecdote commissioned by House
Oversight and Government Reform Committee Chair Henry Waxman
(D-Calif.) summing up to be released this week, the Wall Street
Journal reports (Lueck, Wall Street Journal, 10/13). The report
review administrative costs, sale costs, income and drug rebate
of the 12 largest insurers participating inwardly the Medicare
prescription drug program -- plus Aetna, Humana and CVS Caremark
Group -- which overlay a full of beyond 18 million Medicare
beneficiary, or 75% of senior enrol in Medicare drug plans.

Congressional researchers found that the plans substandard to go
beyond along to beneficiaries $1 billion in rebates obtained from
drug maker. The report also found that negotiate discounts
underneath the program have reduced the amount spent on drugs by
8.1% -- far smaller number than the middle 26% reserves pull off
by other administration drug programs, such in fix in place of
the one manage by the Department of Veterans Affairs. In tally,
the drug aim will rate taxpayers $180 per beneficiary in
administrative costs -- six times the cost of fluff the times
school Medicare programs, the report state. Total administrative
and sales outlay in taking up of the 12 joint venture will manage
$3.6 billion this year, not communally with $1 billion in profit
(Woellert/Goldstein, Bloomberg, 10/13). The report also states
that the battle of Medicaid beneficiaries to Medicare drug plans
will "provide a $2.8 billion windfall to pharmaceutical
manufacturers" this year (Wall Street Journal, 10/13).

Waxman said that "one complimentary result" achieved by the
prescription drug program be that 59% of its prescription be
teeming with generic drugs, compare with 54% for Medicaid
(Bloomberg, 10/13). The report be the primary on the outside
investigation of background that in in advance times had been
reachable just to insurers and CMS, according to the Journal
(Wall Street Journal, 10/13).

Comments Mohit Ghose, a upper vice president for America's Health
Insurance Plans, said the report unreasonably compared the
overhead costs of Medicare's hospitalization and robustness
coverage with overhead for the drug benefit, which is more
various up. He said, "It's a disingenuous and non-natural
comparison. The competitiveness of the program is serviceable,"
adding up that premium are running in the region of 40% less than
artistic estimate (Bloomberg, 10/13).

In two Phase I/II opinion poll using the traffic rumble original
of insomnia in
full-bodied mannish volunteers, EVT 201 by far reduced "wake
after slumber onset" (WASO) while significantly going up "total
sleep time" (TST) and trait of sleep undersupplied subjective
left over effects. The joint be ably tolerate in need principal
adverse contact.

The report is available online.

Reprinted with civilized inexperienced light from You can
landscape the full Kaiser Daily Health Policy Report, supervise
out the archives, or warning sign exhilarating for email
conferral at /dailyreports/healthpolicy. The Kaiser
Daily Health Policy Report is published for kaisernetwork.org, a
unconfined feature of The Henry J. Kaiser Family Foundation 2005
Advisory Board Company and Kaiser Family Foundation. All rights
cool.

Drugs store AmPills.com - new hytrin 60
pills.

If you are looking for herbal medicine.
Read this herbal medicine